Electronic Trial Master File Systems Market - Analysis And Opportunities

Posted by robert henric on April 20th, 2022

According to the new market research report Electronic Trial Master File (eTMF) Systems Market by Component (Services, Software), End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations), Delivery Mode (On-Premise, Cloud-Based), and Region – Global Forecast to 2024″, published by MarketsandMarkets™, the eTMF systems market is projected to reach USD 1.8 billion by 2024 from USD 1.0 billion in 2019, at a CAGR of 12.7%

Report Objectives Coverd in Research;

- To define, describe, segment, and forecast the eTMF systems market by delivery mode, component, end-user, and region

- Will provide detailed information about the factors (such as drivers, restraints, opportunities, and challenges) influencing market growth

- To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market

- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

- To forecast the size of the market segments with respect to four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94357456

The Factors such as rising adoption of eTMF systems, rising number of clinical trials, partnerships between biopharma companies and CROs, rising funding to support clinical trials, and the growth in the R&D spending by pharma & biotech companies are driving the growth of the eTMF Systems Market.

The cloud-based eTMF to register the highest CAGR during the forecast period

Based on delivery mode, the eTMF Systems Market is segmented into on-premise and cloud-based eTMF. The cloud-based eTMF segment is expected to register the highest CAGR during the forecast period. Growth in this segment can be attributed to the comparatively lower capital expenses & operational costs incurred in this model, alongside its scalability, flexibility, and affordability.

Cloud-based solutions help healthcare organizations share and integrate information from different locations, making the process of data gathering seamless. Moreover, these solutions are comparatively affordable to install and maintain as compared to on-premise solutions, thus contributing to the high growth and popularity of the cloud-based delivery model.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=94357456

North America dominated the Electronic Trial Master File Systems Market  in 2018; this trend to continue during the forecast period

Geographically, the eTMF Systems Market is divided into North AmericaEuropeAsia Pacific, and the Rest of the World (RoW). The North American market accounted for the largest share of the Electronic Trial Master File (eTMF) Systems Market in 2018, primarily due to the increasing government funding for clinical research and a large number of clinical trials. Several major global players are also based in the US, owing to which the country has become a center of innovation in the eTMF Systems Market

Veeva Systems (US), Oracle Corporation (US), Phlexglobal Limited (UK), TransPerfect Global Inc. (US), Aurea Software (US), LabCorp (US), ePharmaSolutions (US), Wingspan Technology, Inc. (US), MasterControl (US), SureClinical, Inc. (US), Dell EMC (US), Paragon Solutions (US), PharmaVigilant (US), Mayo Clinic (US), Database Integrations, Inc. (US), CareLex (US), Ennov (France), Forte Research (US), Freyr (US), Montrium (US), NCGS Inc. (US), SAFE-BioPharma (US), SterlingBio Inc. (US), BIOVIA Corp. (US), and arivis AG (Germany) are the key players in the Electronic Trial Master File (eTMF) Systems Market.

Veeva Systems was the leading player in the electronic trial master file (eTMF) systems market in 2018. The company’s dominant position can be attributed to its solution, Veeva Vault eTMF. The company focuses on various inorganic and organic growth strategies such as solution deployments and expansions to maintain and enhance its market share. In the last three years, Veeva Systems has deployed its solutions at more than ten pharmaceutical companies, CROs, and other sites in the US to expand its user base with the development of innovative solutions. The company also has a strategic focus on expansions in growing emerging markets, such as the Middle East and Asia.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=94357456

Like it? Share it!

robert henric

About the Author

robert henric
Joined: July 3rd, 2019
Articles Posted: 388

More by this author